Similares a ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More | HCPLive Expert Interviews

20 vecinos (text_768) · 70 views · HCPLive · Estados Unidos


★	ATS 2026 Asthma Updates: Tezepelumab, Dupilumab, OCS Reduction & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	70	Estados Unidos
8	Mepolizumab Add-On Reduces COPD Exacerbations in Triple-Therapy Patients \| ATS 2026	HCPLive @hcplivenews	1.2K	Estados Unidos	87
7	Potential Biomarker to Identify Pregnant Women at Greater Risk for #Asthma Exacerbations I ATS 2026	HCPLive @hcplivenews	453	Estados Unidos	87
18	Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD \| ATS 2026	HCPLive @hcplivenews	301	Estados Unidos	85
16	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	86
14	AD109 Shows Promise as Oral Agent for Obstructive Sleep Apnea, With Patrick John Strollo, MD	HCPLive @hcplivenews	129	Estados Unidos	86
3	Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes \| ATS 2026	HCPLive @hcplivenews	122	Estados Unidos	90
10	Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease \| ATS 2026 With Gerard Criner, MD	HCPLive @hcplivenews	113	Estados Unidos	86
20	What is on the Horizon for Pediatric #AtopicDermatitis Treatment	HCPLive @hcplivenews	111	Estados Unidos	85
6	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos	88
19	What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis?	HCPLive @hcplivenews	92	Estados Unidos	85
2	SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma	HCPLive @hcplivenews	78	Estados Unidos	91
9	How to Sequence Omalizumab, Dupilumab, and Remibrutinib in CSU	HCPLive @hcplivenews	74	Estados Unidos	87
4	Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma:	HCPLive @hcplivenews	71	Estados Unidos	90
13	Robert Wood, MD, on Age, Dosing in Multifood Allergy OIT	HCPLive @hcplivenews	70	Estados Unidos	86
5	Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients \| ATS 2026	HCPLive @hcplivenews	68	Estados Unidos	90
12	Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More \| EAC 2026	HCPLive @hcplivenews	58	Estados Unidos	86
1	ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More \| HCPLive Expert Interviews	HCPLive @hcplivenews	55	Estados Unidos	91
15	Diabetes Dialogue: Teplizumab, Stelo, and Inhaled Insulin Afrezza for Pediatric Patients	HCPLive @hcplivenews	53	Estados Unidos	86
11	Biologic Selection in Severe Asthma: Biomarkers, Comorbidities & Switching Strategies	HCPLive @hcplivenews	36	Estados Unidos	86
17	Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA	HCPLive @hcplivenews	30	Estados Unidos	85